Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker-high and -low severe asthma. (2022)

First Author: Khalfaoui L
Attributed to:  United Kingdom Refractory Asthma Stratification Programme (RASP-UK) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/all.15376

PubMed Identifier: 35579040

Publication URI: http://europepmc.org/abstract/MED/35579040

Type: Journal Article/Review

Volume: 77

Parent Publication: Allergy

Issue: 10

ISSN: 0105-4538